Back to Search
MICHAEL BOYIADZIS, MD
MD
Specialist
NPI: 1255303343Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
MD425571(PA)
Research & Publications (13)
Hematopoietic stem cell transplantation for chronic lymphocytic leukemia: potential cure for an incurable disease.
PMID 18034645·Expert Opin Biol Ther·2007
6-review
NK cells in cancer immunotherapy: three decades of discovery.
PMID 17250791·Discov Med·2006
7-preclinical
Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors.
PMID 19526239·Cancer Immunol Immunother·2010
8-other
Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia.
PMID 19417016·Clin Cancer Res·2009
8-other
Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.
PMID 19318560·Cancer Res·2009
8-other
Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia.
PMID 19075274·J Clin Oncol·2009
8-other
Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels.
PMID 18275895·Biol Blood Marrow Transplant·2008
8-other
Haematopoietic stem cell transplantation: indications, clinical developments and future directions.
PMID 14680439·Expert Opin Pharmacother·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 MEYRAN AVE, SUITE 318
PITTSBURGH, PA 15213 - Phone
- (412) 586-9874
Quick Facts
- NPI
- 1255303343
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 13
Are you this provider?
Claim Your Profile